Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.

<h4>Background</h4>Young male cancer survivors have lower testosterone levels, higher fat mass, and worse quality of life (QoL) than age-matched healthy controls. Low testosterone in cancer survivors can be due to orchidectomy or effects of chemotherapy and radiotherapy. We have undertak...

Full description

Bibliographic Details
Main Authors: Jennifer S Walsh, Helen Marshall, Isabelle L Smith, Diana M Greenfield, Jayne Swain, Emma Best, James Ashton, Julia M Brown, Robert Huddart, Robert E Coleman, John A Snowden, Richard J Ross
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-11-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1002960

Internet

https://doi.org/10.1371/journal.pmed.1002960

Similar Items